Results 191 to 200 of about 93,748 (310)

Analysis of vasodilating action of Daio-Teng extract (DTE), an antihypertensive drug: EDRF releasing action in the isolated rat aorta

, 1992
Tomoya Kuramochi, Jie Chu, Toshio Suga
openalex   +1 more source

The antihypertensive effect of propranolol : an animal study into the mechanisms through which beta-adrenoceptor blocking drugs lower blood pressure [PDF]

, 1980
Jos F.M. Smits
openalex   +1 more source

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of pancreatic cancer: a mendelian randomization analysis. [PDF]

BMC Cancer
Yao Z, Qin D, Cao J, Gao C, Xi P, Li S, Wei R.   +6 more
europepmc   +1 more source

Effects of Antihypertensive Drugs on Alveolar Bone Loss in Patients with Chronic Periodontitis: A Retrospective Study

, 2018
Fouad Al‐Bayaty, OE Ibrahim, C William, NA Khairuddin   +3 more
openalex   +2 more sources

Polypharmacy and potentially inappropriate prescribing in people with type 2 diabetes: An analysis of the Scottish Diabetes Research Network national diabetes cohort

Diabetic Medicine, EarlyView.
Abstract Aims This study assesses national trends and, socio‐demographic and clinical factors associated with polypharmacy and potentially in appropriate prescribing among people with type 2 diabetes in Scotland from 2012 to 2022. Methods Retrospective cohort study using nationwide data from the Scottish Care Information – Diabetes database ...
William Berthon, Stuart J. McGurnaghan, Luke A. K. Blackbourn, Amanda de Assuncao Santiago Fernandes, Lauren E. Walker, Rory J. McCrimmon, Helen M. Colhoun, David A. McAllister, Peter Hanlon   +8 more
wiley   +1 more source

Antihypertensive Drug Use and COVID-19 Disease Severity in Hospitalized US Veterans: A Retrospective Cohort Study. [PDF]

J Clin Hypertens (Greenwich)
Huntsman M, Marquez JL, Stoddard GJ, Wei G, Miller AJ, Agarwal JP, Jeyapalina S.   +6 more
europepmc   +1 more source

Real‐world evaluation of clinical outcomes in Dutch patients with type 2 diabetes treated with oral semaglutide: A retrospective, observational cohort study using the PHARMO data network

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim A retrospective observational cohort study, in the Netherlands, evaluated clinical outcomes with oral semaglutide. Methods Glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) naïve type 2 diabetes (T2D) patients who initiated oral semaglutide between 1 January 2020 and 31 December 2022 were identified from the PHARMO Data Network.
Abigail Postema, Jordy Gaspersz, Brenda N. Baak, Eline L. Huisman, Charlotte Hoogstraten, Lise Meinicke Hagelund, Fernie J. A. Penning‐van Beest, Jetty A. Overbeek   +7 more
wiley   +1 more source

Cost-Effectiveness of Salt Substitution and Antihypertensive Drug Treatment in Chinese Prehypertensive Adults. [PDF]

Hypertension
Sun Z, Zhang H, Ding Y, Yu C, Sun D, Pang Y, Pei P, Yang L, Chen Y, Du H, Hu W, Avery D, Chen J, Chen Z, Li L, Lv J, China Kadoorie Biobank Collaborative Group†.   +16 more
europepmc   +1 more source

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims To evaluate the lipid‐lowering efficacy, safety, and adherence of switching from moderate‐ or low‐intensity statin monotherapy to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus (T2DM) and dyslipidaemia.
Sangmo Hong, Won J. Kim, Sungrae Kim, Jung H. Park, Eun S. Kang, Min K. Moon, Jae T. Kim, Ji‐Oh Mok, Ki Y. Lee, Cheol‐Young Park, Chang B. Lee   +10 more
wiley   +1 more source

Correction to "Dissecting Causal Relationships Between Antihypertensive Drug, Gut Microbiota, and Type 2 Diabetes Mellitus and Its Complications: A Mendelian Randomization Study". [PDF]

J Clin Hypertens (Greenwich)
europepmc   +1 more source